12.1 Neonatal Resuscitation, Physiological vs. Pathological Jaundice, and Neonatal Sepsis

Key Takeaways

  • In ERC 2025 newborn life support, start respiratory support promptly for ineffective breathing or a heart rate below 100/min. Use five initial inflations for apnoea, gasping or ineffective breathing. At 32 weeks or later, start at 30 cm H₂O in room air. Before 32 weeks, start at 25 cm H₂O with 30% oxygen.

  • Begin chest compressions only if the heart rate remains below 60/min after at least 30 seconds of effective ventilation. Use a 3:1 compression-to-ventilation ratio and increase oxygen to 100% at the start of compressions.

  • Jaundice in the first 24 hours needs urgent serum bilirubin and medical review for an underlying cause. Treat using the applicable age-in-hours and gestation-specific threshold.

  • A term infant still jaundiced after two weeks needs fractionated bilirubin. Pale stool, dark urine or an elevated direct bilirubin warrants prompt assessment for cholestasis and timely referral for possible biliary atresia.

  • A symptomatic newborn needs urgent sepsis assessment and IV antibiotics. In Irish maternity units IV benzylpenicillin and gentamicin are usual for suspected early-onset infection in this setting. Dose and adapt treatment by local neonatal guidance.

Last updated: November 2026

Newborn life support at birth (ERC 2025)

Before delivery, identify risk factors, brief the team and check warmth, ventilation equipment and escalation arrangements. At birth assess breathing, heart rate and tone while keeping the infant warm. A vigorous term infant can usually have skin-to-skin care with observation. Defer cord clamping for at least 60 seconds when immediate resuscitation is unnecessary. When immediate resuscitation requires moving the infant, clamp early to avoid delaying support. When intact-cord stabilisation is feasible, longer deferral is preferred, especially in preterm infants.

Establish lung aeration

  1. Warm the infant, position the head neutrally and gently stimulate. Dry and remove wet linen for term infants. For a very preterm infant under 32 weeks, use a plastic wrap or bag over the body without drying it first and provide radiant heat. Keep the face exposed and monitor temperature.
  2. Start respiratory support if breathing is ineffective or heart rate is below 100/min. For apnoea, gasping or ineffective breathing, start positive pressure ventilation promptly, ideally by 60 seconds of age. Auscultate the heart, with ECG or pulse oximetry when available during support. Apply the pulse oximeter to the right hand or wrist for a preductal reading. Apply the monitor without delaying ventilation.
  3. Give five inflations, each held up to 2–3 seconds. Start at 30 cm H₂O and 21% oxygen at 32 weeks or later, or 25 cm H₂O and 30% oxygen below 32 weeks. Start positive end-expiratory pressure at 6 cm H₂O when giving positive pressure ventilation. Adjust inspired oxygen against reliable preductal saturation and time since birth. A spontaneously breathing infant with respiratory distress may need CPAP.
  4. Check for chest movement during inflations and for a rise in heart rate. With an effective response, continue ventilation at about 30 breaths/min, around one second per breath, as needed until effective spontaneous breathing and sustained heart rate above 100/min. Reassess about every 30 seconds.

If the chest fails to move

Call for experienced help. Check equipment, mask seal, head position and jaw support. Use a two-person technique if available. If the airway is open but the lungs still fail to inflate, raise inflation pressure as needed and reassess after repeat inflations. Consider a supraglottic airway or tracheal tube if ventilation via mask remains ineffective and the required skill and equipment are present. Use suction under direct vision for a suspected obstruction. Routine suction, including for meconium-stained fluid, can delay ventilation.

An increased heart rate is a strong sign of effective ventilation. A flat response and absent chest rise point first to inadequate lung aeration. Correct this before judging whether compressions are indicated.

Loading diagram...
ERC 2025 newborn life support at birth

Compressions and medicines

If heart rate stays below 60/min after at least 30 seconds of effective ventilation, give coordinated 3:1 compressions and breaths. Start compressions with 100% oxygen and titrate with a reliable saturation reading. Use the two-thumb encircling grip, with thumbs on the lower third of the sternum. Compress to about one-third of chest depth and allow recoil. At 30 cycles/min the team delivers 90 compressions and 30 ventilations per minute. Reassess heart rate every 30 seconds. If it exceeds 60/min and output is confirmed, stop compressions and continue ventilatory support as needed.

If the rate remains below 60/min and is failing to rise after at least 30 seconds of coordinated compressions and effective ventilation, give adrenaline. An umbilical venous catheter is the usual first choice at birth. Intraosseous access is an alternative. ERC 2025 gives 10–30 micrograms/kg via either route using 0.1 mg/mL adrenaline (0.1–0.3 mL/kg), repeated every four minutes if indicated. An intubated infant without either form of vascular access can receive 100 micrograms/kg intratracheally while access is established. If the rate remains below 60/min once access is available, give the vascular dose immediately.

Worked calculation: a 3 kg infant prescribed 20 micrograms/kg by umbilical venous catheter needs 60 micrograms. At 0.1 mg/mL (100 micrograms/mL), the volume is 0.6 mL. The intratracheal dose is a different dose and route.

Consider 10 mL/kg of group O RhD-negative blood for suspected blood loss, using isotonic crystalloid if suitable blood is unavailable. If the infant fails to respond, reassess for occult blood loss, pneumothorax, equipment failure and congenital causes. A trial of volume may be considered after adequate resuscitation if hypovolaemia remains possible. Check glucose during resuscitation if possible. ERC gives 2 mL/kg of 10% glucose (200 mg/kg) if the measured glucose is low. After stabilisation monitor temperature, oxygenation, perfusion and glucose and involve the neonatal team. For suspected hypoxic-ischaemic encephalopathy, promptly assess eligibility for therapeutic hypothermia under the specialist protocol. Document interventions and response and keep the parents informed. Follow the maternity unit's postnatal glucose pathway for clinically stable at-risk infants.

Assess a cyanosed newborn after initial transition

Central cyanosis, including a blue tongue, or persistent low oxygen saturation in a symptomatic newborn needs urgent assessment. Assess airway, breathing, circulation, temperature and glucose. Measure saturation at the right hand and a foot, and compare brachial and femoral pulses and perfusion. Sepsis, lung disease, persistent pulmonary hypertension and critical congenital heart disease can overlap. Weak femoral pulses and poor perfusion raise concern for obstructed systemic blood flow. Critical disease can present without an audible murmur or after a reassuring screening measurement.

Stabilise the infant, involve the neonatal and paediatric cardiac teams urgently and arrange assessment with echocardiography. If a duct-dependent lesion is suspected, discuss prostaglandin E1 and airway monitoring with the neonatal retrieval or cardiac team. Do not delay stabilisation or transfer to obtain a routine screening result or a local scan. The oxygen and heart-rate targets for resuscitation at birth apply to that separate clinical situation.

HSE paediatric cardiology model, section 15.2 · WHO Europe pocket book, section 5.13.

Neonatal jaundice

Bilirubin from red-cell breakdown initially circulates in the unconjugated form. The liver conjugates it to allow biliary excretion. Newborns often develop transient unconjugated jaundice during transition. Age at onset, infant condition, feeding and weight, and the measured bilirubin guide the initial decision.

Jaundice in the first 24 hours

Irish HSE guidance calls for urgent neonatal or paediatric review and investigation, including referral from the community. NICE CG98 specifies urgent serum bilirubin within two hours and medical review within six hours. Assess for immune haemolysis (such as ABO or RhD incompatibility), other haemolysis including G6PD deficiency or hereditary spherocytosis, or infection when the history or examination suggests it. For significant hyperbilirubinaemia include blood groups, packed cell volume and direct antiglobulin testing as indicated in the local pathway. Interpret the DAT with the maternal antibody history and prophylactic anti-D exposure. Further tests can include a full blood count, film, G6PD assay and infection cultures as indicated. Maternal anti-D prophylaxis prevents RhD sensitisation in eligible unsensitised patients. An affected infant needs assessment and treatment for haemolysis or hyperbilirubinaemia.

Jaundice after 24 hours

Physiological jaundice typically becomes visible around days 2–3 and improves over the first two weeks in term infants. Early jaundice with poor milk transfer, excessive weight loss or low urine/stool output suggests suboptimal intake. Assess a feed, hydration and weight trajectory, support effective feeding and measure bilirubin. Breast milk jaundice is a later, persistent unconjugated pattern in a thriving infant with adequate intake. Confirm the pattern and exclude concerning causes before reassuring. Visual assessment alone cannot quantify bilirubin reliably.

Prolonged jaundice and cholestasis

The HSE newborn examination handbook calls for paediatric reassessment when jaundice persists beyond 14 days. Measure total and direct or conjugated bilirubin. NICE CG98 uses more than 14 days at 37 weeks or later and more than 21 days below 37 weeks as routine workup thresholds. Pale or acholic stool, dark urine staining the nappy, hepatomegaly or clinical illness justify earlier assessment. Verify newborn bloodspot screening, including congenital hypothyroidism, and consider urine culture if a UTI is suspected.

Elevated direct or conjugated bilirubin can indicate cholestasis even when it represents less than 20% of total. NICE calls for expert advice above 25 micromol/L conjugated bilirubin. The joint ESPGHAN/NASPGHAN guideline uses direct bilirubin above about 17 micromol/L for timely evaluation and referral. Interpret the result within the local assay and referral pathway.

Biliary atresia causes progressive bile duct obstruction. A baby may look well and gain weight while passing pale stools. Contact paediatrics promptly for conjugated jaundice and liaise urgently with the CHI hepatology team when biliary atresia is suspected. Specialists may use hepatobiliary ultrasound, liver biopsy and operative cholangiography. Early Kasai portoenterostomy can restore bile drainage and improve native-liver survival. Delayed presentation still needs urgent assessment, with transplantation a possible treatment for advanced disease or failed drainage. Other causes of infant cholestasis include choledochal cyst, infection, alpha-1-antitrypsin deficiency and other metabolic or genetic disease.

FindingWhat it suggestsImmediate decision
Jaundice within 24 hoursPossible haemolysis or illnessUrgent serum bilirubin and medical assessment
Jaundice after 24 hours with poor intake or excess weight lossSuboptimal intake may contributeMeasure bilirubin, assess hydration and support feeding
Persistent jaundice with pale stools or dark urineCholestasis and possible biliary atresiaMeasure the bilirubin fractions and liaise urgently with paediatrics
Persistent unconjugated jaundice in a thriving infantBreast milk jaundice is possible after assessmentReview clinical findings and screening, support feeding and arrange follow-up

Phototherapy, exchange transfusion and bilirubin neurotoxicity

Use the local bilirubin chart for gestation and postnatal age in hours. Plot total serum bilirubin without subtracting the conjugated fraction. Irish postnatal guidance recommends transcutaneous screening at discharge, or at 72 hours if still in hospital. Treatment decisions use serum bilirubin. In the NICE pathway, use serum in the first 24 hours, below 35 weeks’ gestation, or if transcutaneous screening is high or reaches a treatment threshold.

Phototherapy changes bilirubin into forms that can be excreted more readily. Start when the applicable treatment threshold is met. Use eye protection with overhead phototherapy, check temperature and hydration and support feeding. Repeat serum bilirubin according to response and the local chart. Rapid rise or poor response warrants senior neonatal review and escalation. Phototherapy does not relieve biliary obstruction. If the conjugated bilirubin is elevated, evaluate cholestasis while interpreting the total bilirubin with specialists.

Unbound unconjugated bilirubin can injure the brain. Poor feeding, lethargy and hypotonia may be early signs. Hypertonia, arching, a high-pitched cry or recurrent apnoea are concerning for more advanced toxicity. Urgently involve specialists for intensive phototherapy and preparation for exchange transfusion if the bilirubin reaches the exchange threshold or acute bilirubin encephalopathy is suspected. Chronic bilirubin encephalopathy (kernicterus) can cause dystonia, auditory neuropathy or hearing loss, abnormal upward gaze and enamel changes.

Neonatal infection

Early-onset infection in the first 72 hours commonly follows exposure before or around birth. Group B Streptococcus (GBS) and Escherichia coli are important bacterial causes. Consider other pathogens according to the clinical picture, including Listeria monocytogenes in appropriate settings. The Irish GBS prevention guideline effective January 2026 addresses early-onset GBS disease in term infants. Its maternity pathways consider GBS in the current pregnancy, GBS bacteriuria, a previous infant with invasive disease, maternal fever, suspected chorioamnionitis and duration of ruptured membranes. The Irish algorithm includes rupture for more than 18 hours as a risk factor. Use the specific pathway for the woman's obstetric circumstances.

Intrapartum prophylaxis is offered when indicated by the Irish pathway. The Irish guideline uses benzylpenicillin 3 g IV initially, then 1.5–1.8 g IV every four hours until delivery when there is no penicillin allergy. Use local antibiotic and allergy guidance, and treat suspected maternal infection with the appropriate broader regimen. Maternal antibiotic timing modifies risk assessment but does not exclude infection in a symptomatic infant. Well infants with risk factors need assessment and observation or investigation and antibiotics according to the pathway. An infant with signs of sepsis needs urgent evaluation and IV treatment regardless of known maternal risk.

Recognise infection and act promptly

Concerning findings include altered temperature, apnoea, grunting or increased work of breathing, poor feeding, lethargy, abnormal tone, seizures and impaired perfusion. In the 16-hour-old case below, hypothermia, grunting, mottling and prolonged refill together point to systemic illness. Stabilise airway, breathing and circulation, check glucose and call the neonatal team while obtaining a blood culture before antibiotics if feasible without delaying treatment. Baseline and repeat inflammatory markers can help reassess after treatment. A normal early result alone cannot exclude sepsis.

Perform lumbar puncture when strongly indicated and safe, including when signs suggest meningitis. Stabilise shock, respiratory compromise or uncontrolled seizures first. If sampling is unsafe or would delay necessary antibiotics, treat immediately and reconsider sampling after stabilisation. Urine culture and other tests depend on age, setting and suspected source.

Clinical settingEmpirical treatment decision
Suspected early-onset infection on an Irish maternity ward, with no specific meningitic features or conflicting local adviceIV benzylpenicillin plus IV gentamicin is usual. Check gestation, postnatal age, renal function and local dosing and drug-level instructions.
Suspected neonatal meningitisUse the local neonatal meningitis regimen promptly. NICE NG195, as a neonatal-unit example, uses IV amoxicillin and cefotaxime empirically to cover likely organisms with appropriate CNS penetration.
Late-onset illness in a baby already in a neonatal unitConsider indwelling lines, prematurity, local flora and Gram-positive and Gram-negative cover. Coagulase-negative staphylococci, S. aureus and Gram-negative bacteria are relevant. Discuss local therapy and source control.
Ill neonate admitted from homeUse the paediatric community-acquired sepsis or meningitis pathway. Consider urinary infection and HSV in the appropriate clinical setting.

NICE NG195 calls for immediate antibiotics when indicated, within one hour of the decision to treat. Reassess the regimen using cultures, clinical progress and local stewardship guidance. Check ceftriaxone contraindications in the Irish product information. These include preterm neonates up to a postmenstrual age of 41 weeks and term neonates up to 28 days with impaired bilirubin binding or a need for IV calcium. Severe infection, meningitis, suspected necrotising enterocolitis or catheter-related infection needs early specialist advice on antibiotic choice, duration and source control.

Test Your Knowledge

A 39-week infant born by emergency caesarean birth is limp and apnoeic. The team places him under a warmer, positions the head neutrally, dries and gently stimulates him. He remains apnoeic and his heart rate is 72/min. No ventilation has yet been given. What is the next step under ERC 2025 newborn life support?

A

Give five initial inflations lasting up to 2–3 seconds, starting at 30 cm H₂O in room air

B

Start chest compressions at a 3:1 ratio with ventilation in 100% oxygen

C

Intubate immediately to give intratracheal adrenaline

D

Establish umbilical venous access to give a 10 mL/kg crystalloid bolus

Test Your Knowledge

A 17-day-old term breastfed infant is growing and feeding well but has persistent jaundice, pale clay-coloured stools, dark urine and a firm liver edge. Total bilirubin is 138 micromol/L and direct bilirubin is 54 micromol/L. What is the best immediate action?

A

Reassure and continue feeding with routine follow-up for breast milk jaundice

B

Stop breastfeeding for 48 hours and then repeat the bilirubin

C

Arrange urgent paediatric assessment and liaison with the CHI hepatology team for possible biliary atresia

D

Start community phototherapy and repeat the bilirubin in two weeks

Test Your Knowledge

A 16-hour-old term infant on an Irish postnatal ward develops poor feeding, grunting, lethargy, a temperature of 35.4°C and a capillary refill of four seconds. His mother had documented GBS in this pregnancy and membranes ruptured 26 hours before birth. She received no intrapartum prophylaxis. The neonatal team is stabilising the infant and has drawn a blood culture. There are no specific meningitic features, and local surveillance has not indicated a regimen change. Which is the usual initial empirical antibiotic regimen?

A

IV vancomycin and oral fluconazole

B

IV benzylpenicillin and IV gentamicin

C

IV ceftriaxone alone

D

Oral co-amoxiclav and oral erythromycin

Test Your Knowledge

A previously well term newborn is two days old and now has poor feeding, a blue tongue and weak femoral pulses. An oxygen saturation check before discharge had been reassuring. What is the best immediate plan?

A

Repeat routine screening tomorrow because the earlier result was normal

B

Observe for a murmur before deciding whether to escalate

C

Assess and stabilise urgently, contact neonatal and cardiac teams and consider duct-dependent disease while investigating other causes

D

Treat the colour change as normal peripheral cyanosis

Sections you finish are checked off in the contents.